Skip to main content
Top
Published in: European Journal of Medical Research 1/2021

Open Access 01-12-2021 | Septic Shock | Case report

Observational case series: six neurosurgical patients with septic shock demonstrating clinical improvement after a combination of standard care and blood purification

Authors: A. I. Burov, T. A. Abramov, N. S. Kostritca, D. S. Korotkov, G. V. Danilov, Y. V. Strunina, I. A. Savin

Published in: European Journal of Medical Research | Issue 1/2021

Login to get access

Abstract

Background

For patients with primary brain injury, septic shock is especially dangerous due to the possibility of secondary cerebral damage. The key factor of sepsis-associated brain injury is inflammatory mediators, pathogen and damage-associated molecular patterns (PAMPs, DAMPs) release. Theoretically, blood purification may be beneficial for patients with primary brain injury due to its possibility for fast removal of inflammatory mediators.

Case presentation

We report on six post-neurosurgery septic shock patients treated with combined blood purification (CBP), which included CRRT with high adsorption capacity membrane in combination with CytoSorb adsorber. Clinical improvement in the course of CBP was registered in all patients. Three patients had a stable clinical improvement; the other three patients had only a transient improvement due to underlying neurological and cardiac deficits aggravation. We observed septic shock reversal in four patients. The key observations of the case series are a significant decrease in MOF severity (measured by SOFA score) and in catecholamine need (not statistically significant). By the end of CBP we observed a significant decrease in blood lactate, PCT and IL-6 levels. Two patients demonstrated level of consciousness increase in the setting of CBP therapy measured by GCS and FOUR score.

Conclusion

This case series demonstrates that CBP therapy may have a role for septic shock patients with primary brain injury.
Literature
1.
go back to reference Rhodes A, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med. 2017;43(3):304–77.CrossRef Rhodes A, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med. 2017;43(3):304–77.CrossRef
2.
go back to reference Burkhart CS, Siegemund M, Steiner LA. Cerebral perfusion in sepsis. Crit Care. 2010;14(2):215.CrossRef Burkhart CS, Siegemund M, Steiner LA. Cerebral perfusion in sepsis. Crit Care. 2010;14(2):215.CrossRef
3.
go back to reference Bellaver B, et al. Systemic inflammation as a driver of brain injury: the astrocyte as an emerging player. Mol Neurobiol. 2018;55(3):2685–95.CrossRef Bellaver B, et al. Systemic inflammation as a driver of brain injury: the astrocyte as an emerging player. Mol Neurobiol. 2018;55(3):2685–95.CrossRef
4.
go back to reference Dal-Pizzol F, Tomasi CD, Ritter C. Septic encephalopathy: does inflammation drive the brain crazy? Braz J Psychiatry. 2014;36(3):251–8.CrossRef Dal-Pizzol F, Tomasi CD, Ritter C. Septic encephalopathy: does inflammation drive the brain crazy? Braz J Psychiatry. 2014;36(3):251–8.CrossRef
5.
go back to reference De Vriese AS, et al. Cytokine removal during continuous hemofiltration in septic patients. J Am Soc Nephrol. 1999;10(4):846–53.CrossRef De Vriese AS, et al. Cytokine removal during continuous hemofiltration in septic patients. J Am Soc Nephrol. 1999;10(4):846–53.CrossRef
6.
go back to reference Trager K, et al. Treatment of post-cardiopulmonary bypass SIRS by hemoadsorption: a case series. Int J Artif Organs. 2016;39(3):141–6.CrossRef Trager K, et al. Treatment of post-cardiopulmonary bypass SIRS by hemoadsorption: a case series. Int J Artif Organs. 2016;39(3):141–6.CrossRef
7.
go back to reference Brouwer WP, et al. Hemoadsorption with CytoSorb shows a decreased observed versus expected 28-day all-cause mortality in ICU patients with septic shock: a propensity-score-weighted retrospective study. Crit Care. 2019;23(1):317.CrossRef Brouwer WP, et al. Hemoadsorption with CytoSorb shows a decreased observed versus expected 28-day all-cause mortality in ICU patients with septic shock: a propensity-score-weighted retrospective study. Crit Care. 2019;23(1):317.CrossRef
8.
go back to reference Matsumoto H, et al. The clinical importance of a cytokine network in the acute phase of sepsis. Sci Rep. 2018;8(1):13995.CrossRef Matsumoto H, et al. The clinical importance of a cytokine network in the acute phase of sepsis. Sci Rep. 2018;8(1):13995.CrossRef
9.
go back to reference Poli EC, et al. Cytokine clearance with CytoSorb® during cardiac surgery: a pilot randomized controlled trial. Crit Care. 2019;23(1):108.CrossRef Poli EC, et al. Cytokine clearance with CytoSorb® during cardiac surgery: a pilot randomized controlled trial. Crit Care. 2019;23(1):108.CrossRef
10.
go back to reference Gruda MC et al. Broad adsorption of sepsis-related PAMP and DAMP molecules, mycotoxins, and cytokines from whole blood using CytoSorb® sorbent porous polymer beads. PLoS ONE. 2018;13(1):e0191676.CrossRef Gruda MC et al. Broad adsorption of sepsis-related PAMP and DAMP molecules, mycotoxins, and cytokines from whole blood using CytoSorb® sorbent porous polymer beads. PLoS ONE. 2018;13(1):e0191676.CrossRef
11.
go back to reference Bonavia A, et al. Clinical utility of extracorporeal cytokine hemoadsorption therapy: a literature review. Blood Purif. 2018;46(4):337–49.CrossRef Bonavia A, et al. Clinical utility of extracorporeal cytokine hemoadsorption therapy: a literature review. Blood Purif. 2018;46(4):337–49.CrossRef
12.
go back to reference David S, et al. Effect of extracorporeal cytokine removal on vascular barrier function in a septic shock patient. J Intensive Care. 2017;5:12.CrossRef David S, et al. Effect of extracorporeal cytokine removal on vascular barrier function in a septic shock patient. J Intensive Care. 2017;5:12.CrossRef
13.
go back to reference Matsui T, et al. The effect of continuous renal replacement therapy with the AN69ST membrane on inflammatory markers and the level of consciousness of hemodialysis patients with stroke: comparison with hemodialysis with low blood flow rate. Prilozi. 2018;39(2–3):29.CrossRef Matsui T, et al. The effect of continuous renal replacement therapy with the AN69ST membrane on inflammatory markers and the level of consciousness of hemodialysis patients with stroke: comparison with hemodialysis with low blood flow rate. Prilozi. 2018;39(2–3):29.CrossRef
14.
go back to reference Lees NJ, et al. Combination of ECMO and cytokine adsorption therapy for severe sepsis with cardiogenic shock and ARDS due to Panton-Valentine leukocidin-positive Staphylococcus aureus pneumonia and H1N1. J Artif Organs. 2016;19(4):399–402.CrossRef Lees NJ, et al. Combination of ECMO and cytokine adsorption therapy for severe sepsis with cardiogenic shock and ARDS due to Panton-Valentine leukocidin-positive Staphylococcus aureus pneumonia and H1N1. J Artif Organs. 2016;19(4):399–402.CrossRef
15.
go back to reference Friesecke S, et al. Extracorporeal cytokine elimination as rescue therapy in refractory septic shock: a prospective single-center study. J Artif Organs. 2017;20(3):252–9.CrossRef Friesecke S, et al. Extracorporeal cytokine elimination as rescue therapy in refractory septic shock: a prospective single-center study. J Artif Organs. 2017;20(3):252–9.CrossRef
16.
go back to reference Friesecke S, et al. International registry on the use of the CytoSorb(R) adsorber in ICU patients: study protocol and preliminary results. Med Klin Intensivmed Notfmed. 2019;114(8):699–707.CrossRef Friesecke S, et al. International registry on the use of the CytoSorb(R) adsorber in ICU patients: study protocol and preliminary results. Med Klin Intensivmed Notfmed. 2019;114(8):699–707.CrossRef
17.
go back to reference Hetz H, et al. Septic shock secondary to beta-hemolytic streptococcus-induced necrotizing fasciitis treated with a novel cytokine adsorption therapy. Int J Artif Organs. 2014;37(5):422–6.CrossRef Hetz H, et al. Septic shock secondary to beta-hemolytic streptococcus-induced necrotizing fasciitis treated with a novel cytokine adsorption therapy. Int J Artif Organs. 2014;37(5):422–6.CrossRef
18.
go back to reference Kobe Y, et al. Direct hemoperfusion with a cytokine-adsorbing device for the treatment of persistent or severe hypercytokinemia: a pilot study. Blood Purif. 2007;25(5–6):446–53.CrossRef Kobe Y, et al. Direct hemoperfusion with a cytokine-adsorbing device for the treatment of persistent or severe hypercytokinemia: a pilot study. Blood Purif. 2007;25(5–6):446–53.CrossRef
19.
go back to reference Jain S, Sinha S, Sharma SK, Samantaray JC, Aggrawal P, Vikram NK, Biswas A, Sood S, Goel M, Das M, Vishnubhatla S, Khan N. Procalcitonin as a prognostic marker for sepsis: a prospective observational study. BMC Res Notes. 2014;17(7):458.CrossRef Jain S, Sinha S, Sharma SK, Samantaray JC, Aggrawal P, Vikram NK, Biswas A, Sood S, Goel M, Das M, Vishnubhatla S, Khan N. Procalcitonin as a prognostic marker for sepsis: a prospective observational study. BMC Res Notes. 2014;17(7):458.CrossRef
20.
go back to reference Hawchar F, et al. Extracorporeal cytokine adsorption in septic shock: A proof of concept randomized, controlled pilot study. J Crit Care. 2019;49:172–8.CrossRef Hawchar F, et al. Extracorporeal cytokine adsorption in septic shock: A proof of concept randomized, controlled pilot study. J Crit Care. 2019;49:172–8.CrossRef
Metadata
Title
Observational case series: six neurosurgical patients with septic shock demonstrating clinical improvement after a combination of standard care and blood purification
Authors
A. I. Burov
T. A. Abramov
N. S. Kostritca
D. S. Korotkov
G. V. Danilov
Y. V. Strunina
I. A. Savin
Publication date
01-12-2021
Publisher
BioMed Central
Published in
European Journal of Medical Research / Issue 1/2021
Electronic ISSN: 2047-783X
DOI
https://doi.org/10.1186/s40001-021-00614-7

Other articles of this Issue 1/2021

European Journal of Medical Research 1/2021 Go to the issue